ArticleDiabetes2020

Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.

Mariam Alatrach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.